Awarded contractOpenSuppliesCzech Republic
Léčivý přípravek s obsahem účinné látky pembrolizumab
1 supplier awarded•1 lot awarded•€12.15M awarded
Buyer: Fakultní nemocnice Plzeň / Plzeň, Czech Republic
Published Apr 29, 2024Awarded Apr 24, 2024
Antineoplastic and immunomodulating agents
Awarded value
€12.15M
Estimated value
€12.15M
Awarded at 100% of estimated value
Award date
Apr 24, 2024
Winners
1
Lots awarded
1
Winners
Merck Sharp & Dohme s.r.o.
1 lotPraha - Smíchov, CZE
€12.1M This contract
15 award notices•16 awarded lots•€47.38M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Merck Sharp & Dohme s.r.o. | €12.1M | Antineoplastic and immunomodulating agents (33652000) |